Prototype demo. TrialNavigatorAI is an educational support tool. It does not diagnose, recommend treatment, determine trial eligibility, or replace your oncology team. All clinical decisions belong to your care team. This intake uses synthetic data for demonstration only — please do not enter real patient information.

Step 1 of 6 · Welcome

Let's begin your readiness pathway

TrialNavigatorAI walks alongside patients and caregivers facing recurrent or metastatic head and neck cancer (HNSCC). We'll prepare you for your next oncology conversation — together, step by step.

Your first name *

Are you the patient or a caregiver? *

Age range *

Where do you live? City and state — helps us understand travel options if a clinical trial fits.

Step 2 of 6 · Diagnosis

Tell us about your diagnosis

This helps TrialNavigatorAI surface what's most relevant to your situation. If you don't know an answer, that's completely okay — choose "not sure" and we'll help you figure out what to ask your team.

Where is the cancer located? *

Current stage of disease *

HPV status (if known) Many oropharyngeal cancers are HPV-related. HPV-positive disease often responds differently to treatment — and many trials are looking specifically at this.

Have you started any treatment yet? *

Step 3 of 6 · Records vault

What records do you have on hand?

Having your records organized makes every oncology conversation more productive — and is required for most clinical trial conversations. Tell us what you have, and we'll help you gather what's missing.

Step 4 of 6 · Biomarker readiness

Understanding your biomarkers

Biomarkers are specific features of your cancer that can guide treatment and trial decisions. Here's what may matter most for your situation.

Have any of these biomarkers been tested on your tumor? Select all that apply — or "not sure" if you don't know yet.

Step 5 of 6 · Trial literacy

What clinical trials really are

Most patients are never offered a trial — not because they're not eligible, but because no one walked them through what trials are or how they work. Let's fix that.

A clinical trial is a treatment option

Trials test promising new therapies — sometimes drugs that aren't yet available outside the trial. Joining one means you get current standard care plus the chance at a newer therapy, with extra monitoring from the trial team.

You don't have to be "out of options"

Many trials enroll patients early in their journey, not just after standard treatments fail. Some are designed specifically for newly diagnosed disease. The right time to ask is now — not later.

Trial phases — what they mean

Phase 1 trials test safety and dosing. Phase 2 trials test how well a treatment works. Phase 3 trials compare a new treatment against the current standard. Each phase has different goals and expectations — your oncologist can help you understand which makes sense.

You stay in control

Joining a trial is voluntary. You can leave at any time without losing access to standard care. Your oncologist remains your doctor — the trial team works alongside, not instead of, your existing team.

Have you discussed clinical trials with your oncology team?

Your Readiness Dashboard

Welcome

Based on what you shared, here is your personalized readiness summary — what you have, what to gather next, and questions to bring to your next oncology visit.

—

Calculating your readiness score...

Your situation, in plain language

Questions to bring to your next visit

Suggested next steps

Continue to AI conversation See sample trial pathways Print this summary Back to home